Effect of Quality Improvement Tools in Congestive Heart Failure (CHF)

March 18, 2012 updated by: Abhijeet Basoor, St. Joseph Mercy Oakland Hospital

Decreased Readmissions and Improved Quality of Care With Use of Inexpensive Checklist in Heart Failure

Hypothesis: Quality Improvement tools like "Heart Failure Discharge Checklist" which emphasizes on proper education to patients, ensure appropriate dose titration and counselling improve outcome in congestive heart failure (CHF).

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

96

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Michigan
      • Pontiac, Michigan, United States, 48341
        • St. Joseph Mercy Oakland Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients admitted to SJMO with principal diagnosis of acute decompensated heart failure

Exclusion Criteria:

  • Age less than 18 years
  • Pregnant women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
This arm which was control group, was randomly selected among patients with acute decompensated heart failure in whom the checklist was not used. This group was managed as per the standard guidelines.
Active Comparator: Checklist (intervention) cohort
checklist was used in this group arbitrarily by their treating physician
Other: Checklist cohort
CHF discharge checklist was used arbitrarily by their treating physicians in addition to the standard therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Readmissions
Time Frame: 6 months
Readmission to the hospital for CHF within 6 months of discharge
6 months
Dose titration
Time Frame: patients were followed during the time of hospital stay, average of 5 days
up titration of medications including Beta blocer, ACE inhibitor or ARB was assessed during the hospital stay
patients were followed during the time of hospital stay, average of 5 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Medications prescribed
Time Frame: patients were followed during their hospital stay from admission to discharge, on an average of 5 days
during the hospital stay and at discharge this outcome is measured/assessed
patients were followed during their hospital stay from admission to discharge, on an average of 5 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

St. Joseph Mercy Oakland Hospital

Investigators

  • Principal Investigator: Abhijeet Basoor, MD, St. Joseph Mercy Oakland Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2008

Primary Completion (Actual)

June 1, 2010

Study Completion (Actual)

June 1, 2010

Study Registration Dates

First Submitted

September 30, 2011

First Submitted That Met QC Criteria

October 4, 2011

First Posted (Estimate)

October 5, 2011

Study Record Updates

Last Update Posted (Estimate)

March 20, 2012

Last Update Submitted That Met QC Criteria

March 18, 2012

Last Verified

March 1, 2012

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 11-09-02

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Congestive Heart Failure

Clinical Trials on Checklist cohort

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe